Evidence map›Paper›PMID 36132463›Full record

ArticleNanoscale advances2019

Sumaira Ashraf, Arthur Taylor, Jack Sharkey, Michael Barrow, Patricia Murray, Bettina Wilm, Harish Poptani, Matthew J Rosseinsky, Dave J Adams, Raphaël Lévy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 4 countries.

Sumaira AshrafDepartment of Biochemistry, Institute of Integrative Biology (IIB), University of Liverpool Liverpool UK rapha@liverpool.ac.uk sumaira@liverpool.ac.uk.ORCID https://orcid.org/0000-0001-8005-2393
Arthur TaylorDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine (ITM), University of Liverpool Liverpool UK.
Jack SharkeyDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine (ITM), University of Liverpool Liverpool UK.
Michael BarrowDepartment of Chemistry, University of Liverpool Liverpool UK.ORCID https://orcid.org/0000-0002-1190-1715
Patricia MurrayDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine (ITM), University of Liverpool Liverpool UK.
Bettina WilmDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine (ITM), University of Liverpool Liverpool UK.ORCID https://orcid.org/0000-0002-9245-993X
Harish PoptaniDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine (ITM), University of Liverpool Liverpool UK.
Matthew J RosseinskyDepartment of Chemistry, University of Liverpool Liverpool UK.
Dave J AdamsDepartment of Chemistry, University of Liverpool Liverpool UK.ORCID https://orcid.org/0000-0002-3176-1350
Raphaël LévyDepartment of Biochemistry, Institute of Integrative Biology (IIB), University of Liverpool Liverpool UK rapha@liverpool.ac.uk sumaira@liverpool.ac.uk.ORCID https://orcid.org/0000-0001-5728-0531
University of Liverpool · GB

Funding

Medical Research Council MR/K026739/1
6 · The paper itself

Abstract

Nanoparticle contrast agents are useful tools to label stem cells and monitor the

Identifiers

PMID36132463
PMCPMC9473218
OpenAlexW2884631963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.